Hi secondsight OOPS Chief Operations Officer Company NameDE MOTU...

Hi secondsight
OOPS

• Chief Operations Officer
  
  Company NameDE MOTU CORDIS
  
  Dates EmployedFeb 2017 – Present
  
  Employment Duration5 mos
  
  LocationBrisbane, Australia
  Chief Operations Officer at De Motu Cordis Pty. Ltd (DMC), a medtech startup commercially developing an advanced drug delivery system for critical care patients. The technology has the potential to significantly improve patient outcomes, reducing the long-term health costs of patients following cardiac arrest. Further products within the DMC portfolio leveraging the technology behind the critical care advanced drug delivery system include drug device combinations for improved treatment of hypoglycemia and anaphylaxis.
• 
  Co-Founder and CEO
  
  Company NameGlucotek Inc
  
  Dates EmployedMar 2017 – Present
  
  Employment Duration4 mos
  
  LocationBrisbane, Australia
  Our mission is to make the management of gestational diabetes simple, non-invasive and easy, improving the lives of diabetic mothers and their babies.
• 
  Founder
  
  Company NameFundamedtech
  
  Dates EmployedMar 2015 – Present
  
  Employment Duration2 yrs 4 mos
  
  LocationMontreal, Canada Area
  Fundamedtech is a niche medical technology start-up incubator specializing in complex medical device and digital health products.
  
  While most health technology accelerators and incubators steer clear from ventures pursuing the development of complex medical technologies requiring pre-marketing authorization, this is our core focus.
• Co Founder
  
  Company NameSynaptecha
  
  Dates EmployedJan 2016 – Present
  
  Employment Duration1 yr 6 mos
  
  LocationMontreal, Canada Area
  Synaptecha is a medical technology startup developing smart beautifully designed medical devices to track and monitor patients with chronic illnesses
• Founder
  
  Company NameMSMx
  
  Dates EmployedJan 2016 – Present
  
  Employment Duration1 yr 6 mos
  
  LocationMontreal, Canada Area
  Today there is no simple effective method for diagnosing MS, there is no way of knowing upfront which treatment will be most effective for the patient and result in least side-effects, there is no quick effective means of monitoring response to treatment, treatment adherence and there is no means of being able to predict or prevent relapse, often resulting in hospital admission for treatment depending on severity. MSMx is developing a Diagnostic test with high sensitivity, specificity, strong negative and positive predictive value enabling early treatment of MS and prediction of treatment response in addition to a Wearable Integrated Digital health platform enabling real-time monitoring , trending and machine learning of personal and environmental factors correlated treatment, disease progression and relapse
  
  
  
  
  
• 
  Chief Operations Officer
  
  Company NameAnteo Diagnostics
  
  Dates EmployedJul 2016 – Feb 2017
  
  Employment Duration7 mos
  
  LocationAustralia
  Led the operations and product commercialization for Anteo Diagnostics Limited (ASX: ADO), a global nanotechnology company developing and commercializing products for the life sciences, clinical diagnostics,medical device, energy, and bioseparations markets. The Anteo Group owns a patented nanochemistry surface engineering technology with high-value
  commercial applications in protein binding and anti-body coupling, point of care devices, in-vivo medical devices, medical drug delivery, and batteries